Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Single Dose Bioequivalence Study Of Neratinib In Healthy Subjects

This study has been completed.
Information provided by (Responsible Party):
Puma Biotechnology, Inc. Identifier:
First received: June 9, 2010
Last updated: May 10, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)